Effect of depot medroxyprogesterone acetate on bone density in a Scottish industrial city

European Journal of Contraception and Reproductive Health Care

Volumn 12, Issue 3, 2007, Pages 253-259

  McGough, Pauline ^a   Bigrigg, Alison ^a  

^a Sandyford Initiative   (United Kingdom)

Author keywords

Bone mineral density; Depot medroxyprogesterone acetate; Hormonal contraceptives

Indexed keywords

MEDROXYPROGESTERONE;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAMILY HISTORY; FEMALE; HIP; HIP FRACTURE; HUMAN; INDUSTRIAL AREA; KYPHOSIS; LUMBAR SPINAL CORD; PARITY; PRIORITY JOURNAL; SIDE EFFECT; SMOKING; UNITED KINGDOM;

ABSORPTIOMETRY, PHOTON; ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; BONE DENSITY; CASE-CONTROL STUDIES; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; ESTRADIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY PLANNING SERVICES; FEMALE; FEMUR NECK; HUMANS; LINEAR MODELS; LUMBAR VERTEBRAE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; OBSERVATION; OSTEOPETROSIS; POVERTY AREAS; SCOTLAND; URBAN HEALTH;

EID: 34548301243     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180701475640     Document Type: Article

References (22)

1. Scottish Intercollegiate Guidelines Network. Management of osteoporosis - A National Clinical Guideline. SIGN 71 June 2003.
2. Cundy T, Evans M, Roberts H, et al. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Br Med J 1991;303:13-16.
3. Hickey M, Fraser I. The contraceptive use of depot medroxyprogesterone acetate. Clin Obstet Gynecol 1995;38:849-8.
4. Naessen T, Olsson S-E, Gudmundson J. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women. Contraception 1995;52:35-9.
5. Cromer BA, McArdle Blair J, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996;129:671-6.
6. Taneepanichskul S, Intaraprasert S, Theppisai U, et al. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate: a cross-sectional study of Thai women. Contraception 1997;56:153-5.
7. Taneepanichskul S, Intaraprasert S, Theppisai U, et al. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors. Contraception 1997;56:1-3.
8. Gbolade B, Ellis S, Murby B, et al. Bone density in long-term users of DMPA. BJOG 1998;105:90-4.
9. Cundy T, Cornish J, Evans MC, et al. Recovery of bone density in women who stop using depot medroxyprogesterone acetate. Br Med J 1994;308:247-8.
10. Carstairs V, Morris R. Deprivation and Health in Scotland. Aberdeen University Press 1991.
11. Nguyen TV, Jones G, Sambrook PN, et al. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 1995;80:2709-14.
12. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. Br Med J 1997;314:841-6.
13. Orr-Walker BJ, Evans MC, Ames RW, et al. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women. Clin Endocrinol 1998;49:615-18.
14. MacInnis RJ, Cassar C, Nowson CA, et al. Determinants of bone density in 30- to 65-year old women: a co-twin study. J Bone Min Res 2003;18:1650-6.
15. Berenson AB, Radecki CM, Grady JJ, et al. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001;98:576-82.
16. Scholes D, LaCroix AZ, Ichikawa LE, et al. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology 2002;13:581-7.
17. Cundy T, Cornish J, Roberts H, et al. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception. Am J Obstet Gynecol 2002;186:978-83.
18. Gbolade BA. Depo-Provera and bone density. J Fam Plan Reprod Health Care 2002;28:7-11.
19. Banks E, Berrington A, Casabonne D. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density. BJOG 2001;108:1214-21.
20. Cromer B. Bone mineral density in adolescent and young adult women on injectable or oral contraception. Curr Opin Obstet Gynecol 2003;15:353-7.
21. Westhoff C. Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety. Contraception 2003;68:75-87.
22. Zibners BA, Cromer BA, Hayes J. Comparison of continuation rates for hormonal contraception among adolescents. J Pediatr Adolesc Gynecol 1999;12:90-4.